Publication | Closed Access

2-(Chloromethyl)-3-phenylquinazolin-4(3H)-ones as potent anticancer agents; cytotoxicity, molecular docking and in silico studies

Molecular DockingMedicinal ChemistryHeterocyclicBiochemistryPotent Anticancer AgentsMedicineNatural SciencesPharmacotherapyAnti-cancer AgentHeterocycle ChemistryPharmacologySilico StudiesDrug Discovery